期刊文献+

动物细小病毒新型疫苗研究进展 被引量:2

Progress in Development of Novel Vaccines Against Parvoviruses
下载PDF
导出
摘要 细小病毒是动物病毒中最小最简单的一类单链线状DNA病毒,其在自然界的宿主范围广,感染后呈长期隐性感染,对畜牧养殖业有重要影响。目前,对细小病毒的防治仍以接种减毒疫苗和灭活疫苗为主,但它们仍存在一些不足,如:灭活疫苗成本高;减毒疫苗存在返强的可能性。因此,研制更安全、高效、制备方便的新型疫苗是未来研究的趋势。本文介绍了新型疫苗的发展概况以及近年来细小病毒新型疫苗的研究进展,以期为细小病毒新型疫苗的研究及应用提供参考。 Parvoviruses are the smallest and simplest single-stranded linear DNA viruses among animal viruses.They have a wide host range in nature,causing a long-lasting and inapparent infection and having a big impact on livestock farming.The current commercial vaccines,including inactivated vaccines and attenuated live vaccines,exhibit some defects.The former is costly,and the latter may have a risk of reversion to virulence.Thus,novel vaccines that are safer,more efficient and easier to prepare should be developed in future research.Herein,an overview of novel vaccines and the recent progress in parvovirus vaccine are provided,which would be helpful to further research and application of vaccines against parvoviruses.
作者 曾星翔 汪铭书 程安春 ZENG Xing-xiang;WANG Ming-shu;CHENG An-chun(Institute of Preventive Veterinary Medicine,College of Veterinary Medicine,Sichuan Agricultural University,Chengdu 611130,Sichuan,China;Research Center of Avian Diseases,College of Veterinary Medicine,Sichuan Agricultural University,Chengdu 611130,Sichuan,China;Key Laboratory of Animal Diseases and Human Health of Sichuan Province,Sichuan Agricultural University,Chengdu 611130,Sichuan,China)
出处 《生命科学研究》 CAS CSCD 2021年第6期514-519,525,共7页 Life Science Research
基金 财政部和农业农村部:国家现代农业产业技术体系资助项目 国家农业产业技术体系四川兽药创新团队专项(SCCXTD-2021-18)。
关键词 细小病毒 新型疫苗 DNA疫苗 亚单位疫苗 重组活病毒载体疫苗 parvovirus novel vaccine DNA vaccine subunit vaccine recombinant vector vaccine
  • 相关文献

参考文献6

二级参考文献30

  • 1李茂祥,李俊宝,郑玉美.小鹅瘟病毒纯化及其理化特性的研究[J].病毒学报,1990,6(2):155-159. 被引量:35
  • 2丁忠庆,沈荣显,相文华,赵丽荣,赵立平.IL-2和绵羊梅迪-维斯纳病病毒核心蛋白Gag核酸疫苗联合免疫小鼠的免疫应答[J].中国预防兽医学报,2007,29(3):204-207. 被引量:6
  • 3车茜,程安春,汪铭书,黎敏,韩新锋,卢菲,刘晓东,陈孝跃.鹅细小病毒VP3基因疫苗两种不同免疫方式对细胞免疫的影响[J].中国兽医科学,2007,37(5):401-405. 被引量:5
  • 4Molitor T W, Joo H S, Collett M S. Porcine parvovirus: virus purification and structural and antigenic properties of virion polypeptides[J]. J Virol, 1983,45 (2) 1842-854.
  • 5Rueda P, Fominaya J, Langeveld J P, et al. Effect of different baculovirus inactivation procedures on the integrity and imrnunogenicity of porcine parvovirus-like particles[J]. Vaccine, 2000,19 (7/8) : 726-734.
  • 6Sedlik C, Sarraseca J,Rueda P. Immunogenicity of poliovirus B and T cell epitopes presented by hybrid por-cine parvovirus particles [J]. J Gen Virol, 1995, 76 (9) : 2361-2368.
  • 7Lo-Man R,Rueda P,Sedlik C, et al. A recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Thl immune response without adjuvant[J]. Eur J Immunol, 1998,28(4) : 140-1407.
  • 8Maranga L, Rueda P, Antonis A F, et al. Large, scale production and downstream processing of a recombi- nant porcine parvovirus vaccine [J]. Appl Microbiol Biotechnol, 2002,59(1) :45-50.
  • 9Cotmore S F,Tattersall P. A genome-linked copy of the NS-1 polypeptide is located on the outside of infectious parvovirus particles[J]. J Virol, 1989,63 (9) : 3902- 3911.
  • 10Martinez C,Dalsgaard K,Lopez de Turiso J A,et al. Production of porcine parvovirus empty capsids with high immunogenic activity[J]. Vaccine, 1992,10(10) : 684-690.

共引文献34

同被引文献14

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部